| | |
Prospectus Supplement No. 18 (To Prospectus dated November 12, 2014, as supplemented by prospectus supplements identified on Appendix I hereto) | | Filed pursuant to Rule 424(b)(7) RegistrationNo. 333-199158 |
111,866,539 Shares

Premier, Inc.
Class A common stock
This prospectus supplement number 18 supplements and amends the prospectus dated November 12, 2014, as previously supplemented by the prospectus supplements identified on Appendix I hereto (together, the Prospectus), covering the resale from time to time by selling stockholders named in the Prospectus of up to an aggregate of 111,866,539 shares of our Class A common stock that may be issued in exchange for Class B common units of limited partnership, or Class B common units, in Premier Healthcare Alliance, L.P. (Premier LP) and an equal number of shares of our Class B common stock, pursuant to certain contractual rights of the limited partners of Premier LP. Our wholly-owned subsidiary, Premier Services, LLC, is the general partner of Premier LP. This prospectus supplement is not complete without, and may not be utilized except in connection with, the Prospectus, including any amendments or supplements thereto. This prospectus supplement is qualified by reference to the Prospectus, except to the extent that the information provided by this prospectus supplement supersedes information contained in the Prospectus.
Our Class A common stock is traded on the NASDAQ Global Select Market, or NASDAQ, under the symbol “PINC.” On April 29, 2019, the last reported sales price of our common stock on NASDAQ was $33.57 per share.
Investing in our securities involves risks. You should read carefully and consider the “Risk Factors” included in our most recent Annual Report on Form10-K, as may be updated by our periodic and current reports, all of which is incorporated by reference herein, before investing in our Class A common stock.
Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined if this prospectus supplement is truthful or complete. Any representation to the contrary is a criminal offense.
The date of this prospectus supplement is April 30, 2019.